Plastoquinonyl decyl triphenylphosphonium - Mitotech
Alternative Names: Plastomitin; SkQ-1; SkQ1 eye drops; SkQ1 pill; VisomitinLatest Information Update: 28 Jan 2025
At a glance
- Originator Mitotech
- Class Anti-inflammatories; Benzoquinones; Eye disorder therapies; Halogenated hydrocarbons; Hepatoprotectants; Obesity therapies; Organophosphorus compounds; Small molecules
- Mechanism of Action Antioxidants; Electron transport chain complex protein modulators; Ferroptosis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase III Dry eyes
- Phase II Leber's hereditary optic atrophy
- Preclinical Non-alcoholic steatohepatitis; Obesity
- No development reported Acute kidney injury; Barth syndrome; Dry age-related macular degeneration; Glaucoma; Inflammation; Multiple sclerosis; Neurodegenerative disorders; Uveitis; Wet age-related macular degeneration
Most Recent Events
- 28 Jan 2025 No recent reports of development identified for phase-I development in Dry age-related macular degeneration in Russia (Ophthalmic, Drops)
- 28 Jan 2025 No recent reports of development identified for phase-I development in Glaucoma in USA (Ophthalmic, Drops)
- 15 Nov 2024 Pharmacodynamics data from a preclinical study in Non-alcoholic steatohepatitis presented at the The Liver Meeting 2024: 75th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2024)